<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A899</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 899 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  VERLINA REYNOLDS-JACKSON</p>

<p class=bpuSponsor>District 15 (Hunterdon and Mercer)</p>

<p class=bpuSponsor>Assemblyman  HERB CONAWAY, JR.</p>

<p class=bpuSponsor>District 7 (Burlington)</p>

<p class=bpuSponsor>Assemblywoman  LINDA S. CARTER</p>

<p class=bpuSponsor>District 22 (Somerset and Union)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Assemblymen Wimberly, Sampson, McClellan, Assemblywomen
Tucker, Lopez, Sumter, Speight, Assemblymen Atkins, Spearman, Assemblywomen
Quijano, Pintor Marin, Assemblyman Moen and Assemblywoman Murphy</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Establishes three-year sickle cell disease pilot
program; appropriates $10,200,000. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span>
concerning sickle cell disease and making an appropriation.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      1.   a.   The
Department of Health, in consultation with the Department of Human Services,
shall establish a three year sickle cell disease pilot program, under which
federally qualified health centers shall be selected by the Department of
Health for the purposes of developing and implementing comprehensive sickle
cell disease treatment programs and services.  The Department of Health shall
select federally qualified health centers for participation in the pilot
program on a competitive basis based on criteria to be established by the
Commissioner of Health.  First priority shall be given to federally qualified
health centers located in the municipalities of Jersey City, Newark, Paterson,
Plainfield, Trenton, Camden, and, subject to the availability of funds provided
pursuant to section 2 of this act, to federally qualified health centers in
other municipalities which demonstrate a patient population in that geographic
area that is in need of sickle cell disease care.  The federally qualified
health centers selected for participation in the pilot program shall be
eligible for financial support from funds appropriated to the department
pursuant to section 2 of this act.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   The
purpose of the pilot program shall be to:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  link
outpatient sickle cell disease care to sickle cell disease care in inpatient
health care settings and other health care settings, which may include, to the
extent permitted by law, telehealth services; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)
provide coordinated, comprehensive, team-based medical, behavioral health,
mental health, social support, and other services </span><span
style='color:black'>under the supervision of health care professionals who have
expertise in treating individuals</span><span style='letter-spacing:0pt'> with
sickle cell disease;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)  foster
outreach to individuals and families with sickle cell disease and providers of
medical, nursing, and social services who serve and treat persons with sickle
cell disease; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4)  promote
sickle cell disease education and awareness including, but not limited to,
education and public awareness campaigns in partnership with community
organizations, sickle cell disease awareness groups, and youth organizations;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>       (5)
develop initiatives to build a State medical workforce of clinicians who are
knowledgeable about the diagnosis and treatment of sickle cell disease; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (6)  establish
practices for the collection of in-State data on sickle cell disease to monitor
incidence, prevalence, demographics, morbidity, health care utilization, and
costs.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c.   Federally
qualified health centers seeking to participate in the pilot program shall develop
comprehensive sickle cell disease treatment programs and services that provide
coordinated, comprehensive, team-based medical, behavioral health, mental
health, social support, and monitoring services under the supervision of health
care professionals who have expertise in treating individuals with sickle cell disease.
</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d.   The
Department of Health shall coordinate with federally qualified health centers
participating in the pilot program and other health care facilities and health
care professionals to establish centers of excellence for sickle cell disease research
and innovation, as determined by the Commissioner of Health.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      2.
 There is appropriated from the General Fund to the Department of Health the
sum of $10,200,000, which sum shall be used by the department to support the purposes
of this act through the provision of grants to federally qualified health
centers selected pursuant to subsection a. of section 1 of this act for the
duration of the pilot program.  Any unexpended funds shall revert to the
General Fund once the pilot program expires. </span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3. This act shall take effect immediately
and shall expire three years thereafter.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>     This</span> bill establishes a three-year sickle cell
disease pilot program and appropriates $10,200,000.</p>

<p class=MsoNormal style='line-height:150%'>     Under the bill, the Department
of Health (department), in consultation with the Department of Human Services,
is to establish a three-year sickle cell disease pilot program,<span
style='line-height:150%;letter-spacing:0pt'> under which federally qualified
health centers are to be selected by the department to develop and implement
comprehensive sickle cell disease treatment programs and services.  The
department is to select federally qualified health centers for participation in
the pilot program on a competitive basis based on criteria to be established by
the Commissioner of Health (commissioner).  First priority is to be given to
federally qualified health centers located in Jersey City, Newark, Paterson, Plainfield,
Trenton, Camden, and, subject to the availability of funds, to federally
qualified health centers in other municipalities which demonstrate a patient
population in that geographic area that is in need of sickle cell disease
care.  The federally qualified health centers selected for participation in the
pilot program are to be eligible for financial support from funds appropriated
to the department.</span></p>

<p class=MsoNormal style='line-height:150%'>      The purpose of the pilot
program is to:  </p>

<p class=MsoNormal style='line-height:150%'>      <span style='line-height:
150%;letter-spacing:0pt'>(1)  link outpatient sickle cell disease care to
sickle cell disease care in inpatient health care settings and other health
care settings, which may include, if permitted by law, telehealth services; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (2)  provide coordinated, comprehensive, team-based
medical, behavioral health, mental health, social support, and other services </span><span
style='color:black'>under the supervision of health care professionals </span><span
style='line-height:150%;color:black'>who</span><span style='color:black'> have
expertise in treating individuals</span><span style='line-height:150%;
letter-spacing:0pt'> with sickle cell disease;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (3)  foster outreach to individuals and families with
sickle cell disease and providers of medical, nursing, and social services who
serve and treat persons with sickle cell disease; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (4)  promote sickle cell disease education and
awareness;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (5)  develop initiatives to build a State medical
workforce of clinicians who are knowledgeable about the diagnosis and treatment
of sickle cell disease; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      (6)  establish practices for the collection of
in-State data on sickle cell disease</span><b><sup><span style='line-height:
150%;font-family:"Albertus Extra Bold",sans-serif'> </span></sup></b><span
style='line-height:150%;letter-spacing:0pt'>to monitor incidence, prevalence,
demographics, morbidity, health care utilization, and costs.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      Federally qualified health centers seeking to
participate in the pilot program are to develop comprehensive sickle cell
disease treatment programs and services that</span><b><sup><span
style='line-height:150%;font-family:"Albertus Extra Bold",sans-serif'> </span></sup></b><span
style='line-height:150%;letter-spacing:0pt'>provide coordinated, comprehensive,
team-based medical, behavioral health, mental health, social support, and
monitoring services under the supervision of health care professionals who have
expertise in treating individuals with sickle cell disease.  The department is
to coordinate with federally qualified health centers participating in the pilot
program and other health care facilities and health care professionals to
establish centers of excellence for sickle cell disease</span><b><sup><span
style='line-height:150%;font-family:"Albertus Extra Bold",sans-serif'> </span></sup></b><span
style='line-height:150%;letter-spacing:0pt'>research and innovation, as
determined by the commissioner.</span></p>

</div>

</body>

</html>
